Am. J. Respir. Crit. Care Med., Volume 165, Number 5, March 2002, 694-697

Internet-based Home Monitoring of Pulmonary Function after Lung Transplantation

BIRGIT MORLION, CHRISTIANE KNOOP, MANUEL PAIVA, and MARC ESTENNE

Biomedical Physics Laboratory and Department of Chest Medicine, Erasme University Hospital, Université Libre de Bruxelles, Brussels, Belgium

Home monitoring of spirometry has been advocated in lung transplant recipients for the early detection of acute infection and rejection of the allograft. We have developed a user-friendly, Internet-based telemonitoring system providing direct transmission of home spirometry to the hospital. In this prospective study, we assessed patient adherence with the monitoring, agreement between home and hospital spirometry, intrasubject coefficient of variation (CV) for FEV₁ and FEF_25-75, and sensitivity of these variables for the detection of acute complications. Twenty-two bilateral-lung and heart-lung transplant recipients were followed for a median of 473 d (range, 60-822), during which 13,833 measurements were obtained. Patient compliance was 55% for two measurements a day and 84% for one measurement a day. Agreement between home and hospital spirometry was within 4% for FEV₁ and 6% for FEF_25-75. Mean CV was 3.2% for FEV₁ and 7.5% for FEF_25-75. Using transbronchial lung biopsy and/or bronchoalveolar lavage as gold standards, the sensitivity of home spirometry was 63%, and 23% of true positives were detected by changes in FEF_25-75 alone. We conclude that home monitoring of pulmonary function in lung transplant recipients via the Internet is feasible and provides very reproducible data; yet it has only a mild sensitivity for the detection of acute allograft dysfunction.

This article has been cited by other articles:

				G. Pare, M. Jaana, and C. Sicotte Systematic Review of Home Telemonitoring for Chronic Diseases: The Evidence Base J. Am. Med. Inform. Assoc., May 1, 2007; 14(3): 269 - 277. [Abstract] [Full Text] [PDF]

				C. Knoop, A. Haverich, and S. Fischer Immunosuppressive therapy after human lung transplantation Eur. Respir. J., January 1, 2004; 23(1): 159 - 171. [Abstract] [Full Text] [PDF]

				A. Boehler and M. Estenne Post-transplant bronchiolitis obliterans Eur. Respir. J., December 1, 2003; 22(6): 1007 - 1018. [Abstract] [Full Text] [PDF]

				J. Rigau, F. Burgos, C. Hernandez, J. Roca, D. Navajas, and R. Farre Unsupervised self-testing of airway obstruction by forced oscillation at the patient's home Eur. Respir. J., October 1, 2003; 22(4): 668 - 671. [Abstract] [Full Text] [PDF]

				M. J. Tobin Chronic Obstructive Pulmonary Disease, Pollution, Pulmonary Vascular Disease, Transplantation, Pleural Disease, and Lung Cancer in AJRCCM 2002 Am. J. Respir. Crit. Care Med., February 1, 2003; 167(3): 356 - 370. [Full Text] [PDF]

				M. Estenne and M. I. Hertz Bronchiolitis Obliterans after Human Lung Transplantation Am. J. Respir. Crit. Care Med., August 15, 2002; 166(4): 440 - 444. [Full Text] [PDF]